“Health, risks and disease in therapeutic functionalities of Glucagon-like peptide-1 receptoragonists (GLP-1RAs) concerning human susceptibility”, Grn Int J Apl Med Sci, vol. 3, no. 5, pp. 240–254, Oct. 2025, doi: 10.62046/gijams.2025.v03i05.002.